Continuous Electrocardiographic Monitoring for 24 Hours Before Death in Patients with Terminal Cancer
American Journal of Hospice and Palliative Medicine® · 2024
DOI: 10.1177/10499091231222184 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift American Journal of Hospice and Palliative Medicine®, 2024. Verfasst von Ko Sato und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hospice, Ise Municipal General Hospital, Ise, Japan. Hauptthemen laut MEDLINE: Neoplasms, Terminal Care. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japan Hospice Palliative Care Foundation.
Abstract (Originalsprache)
Background
Purposeless physiological monitoring at the end-of-life is not recommended. However, studies on how families feel regarding the death of patients with terminal cancer without continuous electrocardiographic monitoring (CEM) are lacking.
Objectives
To explore the impact on the quality of care and the feelings and psychological distress experienced by families when CEM is not used during the 24 hours preceding a patient’s death.
Methods
In this multicenter cross-sectional, self-report questionnaires were distributed to 1087 bereaved families at Japanese specialized palliative care units in 2018.
Results
Out of 671 responses, 394 valid responses were analyzed. Families of nonmonitored patients (NM-group) accounted for 79.2%, while those with bedside electrocardiogram monitoring (MB-group) and remote nurse station monitoring (MC-group) comprised 11.9% and 8.9%, respectively. In the NM-group, 85.5% expressed satisfaction without CEM, which was more than 10% lower than other groups. While 14% in the NM-group desired patient monitoring, families who received adequate explanations about CEM had lower proportions compared to the MB-group ( P = .021). Univariate analyses showed no significant differences in evaluations of the quality of care and families’ psychological distress (mean scores of Overall Care Satisfaction, Care Evaluation Scale, Good Death Inventory, Brief Grief Questionnaires) across all groups.
Conclusion
While the majority of NM-group were satisfied with their patient’s care without CEM, the proportion of dissatisfied families was higher than in other groups. Although not using CEM is not a major hindrance to end-of-life care for patients with terminal cancer, providing sufficient explanations may be important for satisfactory care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospice, Ise Municipal General Hospital, Ise, Japan.
- Department of Palliative Medicine, Suita Tokushukai Hospital, Suita, Japan.
- Palliative and Supportive Care Division, Seirei Mikatahara General Hospital, Hamamatsu, Japan.
- Research Association for Community Health, Hamamatsu, Japan.
- Department of Palliative Nursing, Health Sciences, Tohoku University Graduate School of Medicine, Sendai, Japan.
- Department of Palliative Medicine, Tsukuba Medical Center Hospital, Tsukuba, Japan.
ORCID-Profile: Ko Sato
Förderung
- Japan Society for the Promotion of Science
- Japan Hospice Palliative Care Foundation
Zitieren
APA
Sato, K., Baba, M., Morita, T., Masukawa, K., Shima, Y., Tsuneto, S., Kizawa, Y., & Miyashita, M. (2024). Continuous Electrocardiographic Monitoring for 24 Hours Before Death in Patients with Terminal Cancer. American Journal of Hospice and Palliative Medicine®. https://doi.org/10.1177/10499091231222184
Vancouver
Sato K, Baba M, Morita T, Masukawa K, Shima Y, Tsuneto S, et al. Continuous Electrocardiographic Monitoring for 24 Hours Before Death in Patients with Terminal Cancer. American Journal of Hospice and Palliative Medicine®. 2024. doi:10.1177/10499091231222184
BibTeX
@article{Sato2024,
author = {Sato, Ko and Baba, Mika and Morita, Tatsuya and Masukawa, Kento and Shima, Yasuo and Tsuneto, Satoru and Kizawa, Yoshiyuki and Miyashita, Mitsunori},
title = {Continuous Electrocardiographic Monitoring for 24 Hours Before Death in Patients with Terminal Cancer},
journal = {American Journal of Hospice and Palliative Medicine®},
year = {2024},
doi = {10.1177/10499091231222184}
}
EUVIMED